- Like other manufacturers, life sciences companies are assessing the impacts and potential risks of newly-enacted tariffs. This Q&A addresses some of the frequently asked questions on the topic.
- This ebook addresses the major implications of the new revenue recognition standard for life sciences companies.
- Baker Tilly healthcare consultant Serafin Samson reflects on attending the MedCity News INVEST Twin Cities digital health conference.
- Baker Tilly partners provide insights into funding options for digital health startups in this interview with MedCity News.
- As the healthcare landscape continues its rapid change, pharmaceutical companies are revising their operating models to be more customer-centric and to have greater collaboration with providers.